Progressive studies of paeoniflorin.
- Author:
Li-Rong SUN
1
;
Xiong CAO
;
Feng-Qing HOU
;
Xin-Hong ZHU
;
Tian-Ming GAO
Author Information
1. Department of Neurobiology, Southern Medical University, Guangzhou 510515, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Benzoates;
analysis;
pharmacokinetics;
pharmacology;
Bridged-Ring Compounds;
analysis;
pharmacokinetics;
pharmacology;
Chromatography, High Pressure Liquid;
Drugs, Chinese Herbal;
analysis;
pharmacokinetics;
pharmacology;
Enzyme-Linked Immunosorbent Assay;
Glucosides;
analysis;
pharmacokinetics;
pharmacology;
Humans;
Monoterpenes
- From:
China Journal of Chinese Materia Medica
2008;33(18):2028-2032
- CountryChina
- Language:Chinese
-
Abstract:
Paeoniflorin is one of the bioactive components of Paeonia lactiflora, a traditional Chinese herbal medicine. It is the main monoterpene glucoside isolated from the P. lactiflora in 1963. Since then, researchers have found that paeoniflorin has multifold pharmacological effects. In this review, based on the recent available papers published in PubMed and National Knowledge Infrastructure Data Base, we present the major current approaches in understanding the detection methodology, pharmacokinetics and pharmacology, and toxicology of paeoniflorin.
